Strong Buy
Average AnalystStrong Buy
Top AnalystSlightly Bearish
Stock Target AdvisorHold
Average UserUSD 2.40
0.00 (0.00%)
USD 0.19B
0.89M
USD 14.83(+518.06%)
Based on the Terns Pharmaceuticals Inc stock forecast from 4 analysts, the average analyst target price for Terns Pharmaceuticals Inc is USD 14.83 over the next 12 months. Terns Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Terns Pharmaceuticals Inc is Slightly Bearish, which is based on 2 positive signals and 3 negative signals. At the last closing, Terns Pharmaceuticals Inc’s stock price was USD 2.40. Terns Pharmaceuticals Inc’s stock price has changed by +12.15% over the past week, -24.05% over the past month and -47.37% over the last year.
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.